Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2002
05/10/2002WO2001028580A3 Modulation of angiogenesis
05/10/2002WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto
05/10/2002WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/10/2002WO2001023386A3 Benzodiazepin derivatives, the production and use thereof
05/10/2002WO2000073349A9 Dr4 antibodies and uses thereof
05/10/2002WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response
05/10/2002WO2000067736A3 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone
05/10/2002WO2000058339A3 50 human secreted proteins
05/10/2002WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease
05/10/2002CA2427795A1 Sustained release device for treating conditions of the joint
05/10/2002CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
05/10/2002CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
05/10/2002CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
05/10/2002CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
05/10/2002CA2427394A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
05/10/2002CA2421705A1 New treatments for restless legs syndrome
05/09/2002US20020055643 Tubulin binding ligands and corresponding prodrug constructs
05/09/2002US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
05/09/2002US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/09/2002US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology
05/09/2002US20020055538 Aspirin-triggered lipid mediators
05/09/2002US20020055527 Thiazolium compounds and treatments of disorders associated with protein aging
05/09/2002US20020055518 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease.
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055456 Therapeutic methods that target fractalkine or CX3CR1
05/09/2002US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies
05/09/2002US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
05/09/2002US20020054875 Administering to a patient of inflammatory arthritis a therapeutically effective amount of an antagonist of CX3CR1 function or fractalkine fucntion(a chemokine protein or antibody or newly discovered T-cell, a cell adhesion protein)
05/08/2002EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
05/08/2002EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity
05/08/2002EP1203761A2 Calcium receptor-active compounds
05/08/2002EP1203583A1 Remedies for arthrosis deformans
05/08/2002EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
05/08/2002EP1203092A1 Antisense modulation of map kinase kinase 6 expression
05/08/2002EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14
05/08/2002EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof
05/08/2002EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins
05/08/2002EP1203005A2 25 human secreted proteins
05/08/2002EP1202999A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs
05/08/2002EP1202994A1 New compounds
05/08/2002EP1202988A2 Novel integrin receptor antagonists
05/08/2002EP1202984A1 Novel diphenyl-piperidine derivate
05/08/2002EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
05/08/2002EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/08/2002EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases
05/08/2002EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives
05/08/2002EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha
05/08/2002EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
05/08/2002EP1202954A1 Novel aminobenzophenones
05/08/2002EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle
05/08/2002EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use
05/08/2002EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
05/08/2002EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
05/08/2002EP1202731A2 Method for treating chronic pain using mek inhibitors
05/08/2002EP1202729A1 Phosphate transport inhibitors
05/08/2002EP1202726A2 Method for treating chronic pain using mek inhibitors
05/08/2002EP1202723A2 Use of anti-muscarinic agents for treating skin disorders
05/08/2002EP1202705A2 Composition for restoring defects in calcified tissues
05/08/2002DE10054278A1 Verwendung von Stimulatoren der löslichen Guanylatcyclase zur Behandlung von Osteoporose Use of stimulators of soluble guanylate cyclase for the treatment of osteoporosis
05/08/2002CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
05/08/2002CN1348439A New compounds, their preparation and use
05/08/2002CN1348370A Cyclic protein tyrosine kinase inhibitors
05/08/2002CN1348365A Chewing gum with dental benefits including calcium in a food grade acid
05/08/2002CN1347731A Externally applied Chinese medicine prepn for treating lumbar vertebra disease
05/08/2002CN1347728A Chinese medicine prepn for treating rheumatic osteoarthropathy
05/08/2002CN1347707A Externally applied bone Bi-syndrome treating plaster and its prepn
05/08/2002CN1347704A Family handed traditional Chinese medicine recipe of osteomyelitis treatment
05/08/2002CN1084207C Medicinal liquor and ointment for treating traumatic injury
05/08/2002CN1084197C Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process
05/07/2002US6384202 Cell-specific active compounds regulated by the cell cycle
05/07/2002US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes
05/07/2002US6384041 Bicyclic sPLA2 inhibitors
05/07/2002US6383793 Human osteoclast-derived cathepsin
05/07/2002US6383790 Pyrazolo(3,4-d)pyrimidine based compound; anticarcinogenic agents; antitumor agents
05/07/2002US6383780 2786, a novel human aminopeptidase
05/07/2002US6383484 Antibodies to truncated VEGF-D and thereof
05/07/2002CA2361071A1 Combination therapies for the stimulation of bone growth
05/02/2002WO2002035235A2 Net as regulator of angiogenic expression
05/02/2002WO2002034940A2 Methods for screening compounds that modulate lipid metabolism
05/02/2002WO2002034895A2 Novel aggrecanase molecules
05/02/2002WO2002034783A2 Transmembrane proteins
05/02/2002WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis
05/02/2002WO2002034761A1 Pyranoside derivatives
05/02/2002WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
05/02/2002WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE
05/02/2002WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
05/02/2002WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002WO2002034303A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
05/02/2002WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
05/02/2002WO2002034252A1 Drug composition comprising dipeptydyl aldehyde derivative
05/02/2002WO2002034240A2 Delayed and sustained release formulations and method of use thereof
05/02/2002WO2002034236A2 Lipid formulations for target delivery
05/02/2002WO2002034204A2 Calcilytic compounds
05/02/2002WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
05/02/2002WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS
05/02/2002WO2001096397A3 Cd154 variants and uses thereof
05/02/2002WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)